Relmada Therapeutics, Inc.(RLMD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RLMD Relmada Therapeutics, Inc.

休市中 02-13 16:00:00 EST

3.72

-0.18

-4.62%

盘后3.70

-0.02-0.54%

17:59 EST

最高3.93	最低3.72	成交量19.89万
今开3.90	昨收3.90	日振幅5.29%
总市值2.73亿	流通市值2.35亿	总股本7,333万
成交额75.33万	换手率0.31%	流通股本6,315万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RLMD","market":"US","secType":"STK","nameCN":"Relmada Therapeutics, Inc.","latestPrice":3.72,"timestamp":1771016400000,"preClose":3.9,"halted":0,"volume":198882,"hourTrading":{"tag":"盘后","latestPrice":3.7,"preClose":3.72,"latestTime":"17:59 EST","volume":2434,"amount":9044.9503,"timestamp":1771023584483,"change":-0.02,"changeRate":-0.005376,"amplitude":0.005376},"delay":0,"changeRate":-0.04615384615384608,"floatShares":63149200,"shares":73333622,"eps":-1.769318,"marketStatus":"休市中","change":-0.18,"latestTime":"02-13 16:00:00 EST","open":3.9,"high":3.9265,"low":3.72,"amount":753334.3881720001,"amplitude":0.052949,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.769318,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1771318800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":3.9,"preHourTrading":{"tag":"盘前","latestPrice":3.86,"preClose":3.9,"latestTime":"08:31 EST","volume":230,"amount":887.8,"timestamp":1770989509627,"change":-0.04,"changeRate":-0.010256,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":3.7,"preClose":3.72,"latestTime":"17:59 EST","volume":2434,"amount":9044.9503,"timestamp":1771023584483,"change":-0.02,"changeRate":-0.005376,"amplitude":0.005376},"volumeRatio":0.3954893705455382,"impliedVol":1.347,"impliedVolPercentile":0.3705},"requestUrl":"/m/hq/s/RLMD/tweets","defaultTab":"tweets","newsList":[{"id":"1134387842","title":"Relmada Therapeutics发布监管进展，确认与FDA就Ndv-01两项独立适应症注册研究设计达成一致","url":"https://stock-news.laohu8.com/highlight/detail?id=1134387842","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134387842?lang=zh_cn&edition=full","pubTime":"2026-01-12 20:02","pubTimestamp":1768219346,"startTime":"0","endTime":"0","summary":"生物制药公司Relmada Therapeutics, Inc.近日公布了一项关键的监管动态。公司已确认与美国食品药品监督管理局（FDA）就其核心在研药物Ndv-01的两项独立适应症的注册研究设计达成共识。这一重要进展标志着Ndv-01的临床开发路径获得了监管机构的明确认可，为后续推进关键性注册试验奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLMD","BK4007"],"gpt_icon":0},{"id":"1141123003","title":"Relmada Therapeutics, Inc.：瑞穗证券将评级从中性上调至跑赢大盘，并将目标价提升至10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1141123003","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141123003?lang=zh_cn&edition=full","pubTime":"2025-11-19 17:05","pubTimestamp":1763543112,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics, Inc.：瑞穗证券将评级从中性上调至跑赢大盘，并将目标价提升至10美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLMD","BK4007"],"gpt_icon":0},{"id":"1194870725","title":"Relmada Therapeutics公布1亿美元的普通股和预付认股权证承销发行定价","url":"https://stock-news.laohu8.com/highlight/detail?id=1194870725","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194870725?lang=zh_cn&edition=full","pubTime":"2025-11-04 20:10","pubTimestamp":1762258209,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics公布1亿美元的普通股和预付认股权证承销发行定价","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLMD","BK4007"],"gpt_icon":0},{"id":"1140261092","title":"Relmada宣布FDA反馈支持Ndv-01在非肌肉侵袭性膀胱癌的两条独立可接受注册研究路径","url":"https://stock-news.laohu8.com/highlight/detail?id=1140261092","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140261092?lang=zh_cn&edition=full","pubTime":"2025-11-04 20:04","pubTimestamp":1762257852,"startTime":"0","endTime":"0","summary":"Relmada宣布FDA反馈支持Ndv-01在非肌肉侵袭性膀胱癌的两条独立可接受注册研究路径","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLMD","BK4007"],"gpt_icon":0},{"id":"1138412862","title":"Relmada Therapeutics, Inc.任命知名泌尿肿瘤学家Max Kates医生加入临床顾问委员会，支持NDV-01药物开发","url":"https://stock-news.laohu8.com/highlight/detail?id=1138412862","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138412862?lang=zh_cn&edition=full","pubTime":"2025-10-07 19:31","pubTimestamp":1759836684,"startTime":"0","endTime":"0","summary":"Relmada Therapeutics, Inc.宣布任命知名泌尿肿瘤学家Max Kates医生加入临床顾问委员会，以支持NDV-01药物的开发工作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLMD","BK4007"],"gpt_icon":0},{"id":"2511522076","title":"Relmada Therapeutics, Inc.盘中异动 股价大涨5.15%报0.321美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511522076","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511522076?lang=zh_cn&edition=full","pubTime":"2025-02-14 00:15","pubTimestamp":1739463325,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日00时15分，Relmada Therapeutics, Inc.股票出现异动，股价快速拉升5.15%。截至发稿，该股报0.321美元/股，成交量23.9588万股，换手率0.79%，振幅8.76%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.03%。其相关个股中，Edesa Biotech, Inc.、Dominari Holdings Inc.、Pliant Therapeutics, Inc.涨幅较大，Edesa Biotech, Inc.、Tc Biopharm  Plc、Genprex, Inc.较为活跃，换手率分别为2707.91%、1167.95%、162.97%，振幅较大的相关个股有Edesa Biotech, Inc.、Immatics N V C/Wts 01/07/2025 、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为95.15%、92.30%、42.61%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214001525988440c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214001525988440c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","RLMD"],"gpt_icon":0},{"id":"2509253236","title":"Relmada Therapeutics, Inc.盘中异动 下午盘急速上涨5.79%报0.360美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509253236","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509253236?lang=zh_cn&edition=full","pubTime":"2025-02-06 04:00","pubTimestamp":1738785610,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日04时00分，Relmada Therapeutics, Inc.股票出现波动，股价快速拉升5.79%。截至发稿，该股报0.360美元/股，成交量23.2465万股，换手率0.77%，振幅9.23%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.42%。其相关个股中，Immatics N V C/Wts 01/07/2025 、Transcode Therapeutics, Inc.、Invivyd, Inc.涨幅较大，Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃，换手率分别为4655.15%、2388.12%、1767.20%，振幅较大的相关个股有Oragenics Inc.、Transcode Therapeutics, Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为132.24%、99.51%、75.00%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020604001196193c08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020604001196193c08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RLMD","LENZ","BK4007"],"gpt_icon":0},{"id":"2506930526","title":"Relmada Therapeutics, Inc.盘中异动 早盘股价大跌5.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506930526","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506930526?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:56","pubTimestamp":1737989773,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时56分，Relmada Therapeutics, Inc.股票出现波动，股价急速跳水5.94%。截至发稿，该股报0.366美元/股，成交量4.16万股，换手率0.14%，振幅2.83%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.97%。其相关个股中，Akero Therapeutics, Inc.、Onconetix, Inc.、89Bio, Inc.涨幅较大，Onconetix, Inc.、Evaxion Biotech As、Hepion Pharmaceuticals, Inc.较为活跃，换手率分别为1332.79%、160.28%、75.97%，振幅较大的相关个股有阿诺医药、Onconetix, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为98.54%、85.35%、65.16%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127225614a231700d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127225614a231700d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","RLMD","BK4139"],"gpt_icon":0},{"id":"2503257468","title":"Relmada Therapeutics, Inc.盘中异动 早盘股价大涨7.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503257468","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503257468?lang=zh_cn&edition=full","pubTime":"2025-01-14 22:32","pubTimestamp":1736865126,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日22时32分，Relmada Therapeutics, Inc.股票出现异动，股价大幅上涨7.72%。截至发稿，该股报0.435美元/股，成交量1.9783万股，换手率0.07%，振幅0.00%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Eterna Therapeutics Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大，Soligenix, Inc.、Phio Pharmaceuticals Corp.、Eterna Therapeutics Inc.较为活跃，换手率分别为348.45%、218.68%、112.38%，振幅较大的相关个股有Eterna Therapeutics Inc.、Fate Therapeutics, Inc.、Renovaro Inc.，振幅分别为32.98%、14.73%、13.58%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114223206abaaac8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114223206abaaac8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RLMD","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2503588952","title":"Relmada Therapeutics, Inc.盘中异动 股价大涨7.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503588952","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503588952?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:31","pubTimestamp":1736778704,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时31分，Relmada Therapeutics, Inc.股票出现波动，股价大幅上涨7.74%。截至发稿，该股报0.444美元/股，成交量1.9179万股，换手率0.06%，振幅0.00%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.01%。其相关个股中，Salarius Pharmaceuticals, Inc.、Phio Pharmaceuticals Corp.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为2580.35%、1596.43%、389.66%，振幅较大的相关个股有Verrica制药、天境生物、Okyo Pharma Ltd Com Npv ，振幅分别为106.80%、106.67%、101.76%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223144aba93070&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223144aba93070&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","RLMD"],"gpt_icon":0},{"id":"2495626619","title":"Relmada Therapeutics, Inc.盘中异动 股价大跌5.14%报0.435美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2495626619","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495626619?lang=zh_cn&edition=full","pubTime":"2024-12-31 22:40","pubTimestamp":1735656047,"startTime":"0","endTime":"0","summary":"北京时间2024年12月31日22时40分，Relmada Therapeutics, Inc.股票出现波动，股价快速下跌5.14%。截至发稿，该股报0.435美元/股，成交量30.8973万股，换手率1.02%，振幅9.83%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.69%。其相关个股中，知临集团、Onconetix, Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Onconetix, Inc.、知临集团、Eyenovia, Inc.较为活跃，换手率分别为1023.00%、843.14%、163.24%，振幅较大的相关个股有Onconetix, Inc.、知临集团、Eyenovia, Inc.，振幅分别为125.86%、119.56%、47.48%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231224048ab99843f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231224048ab99843f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","RLMD","BK4007"],"gpt_icon":0},{"id":"2493176545","title":"Relmada Therapeutics, Inc.盘中异动 早盘急速上涨8.57%报0.394美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493176545","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493176545?lang=zh_cn&edition=full","pubTime":"2024-12-23 22:32","pubTimestamp":1734964342,"startTime":"0","endTime":"0","summary":"北京时间2024年12月23日22时32分，Relmada Therapeutics, Inc.股票出现异动，股价大幅拉升8.57%。截至发稿，该股报0.394美元/股，成交量11.054万股，换手率0.37%，振幅2.76%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Traws Pharma, Inc.、Rapt Therapeutics, Inc.、Gt Biopharma, Inc.涨幅较大，Phio Pharmaceuticals Corp.、Gt Biopharma, Inc.、Traws Pharma, Inc.较为活跃，换手率分别为663.20%、440.93%、288.06%，振幅较大的相关个股有Traws Pharma, Inc.、Gt Biopharma, Inc.、Neurosense Therapeutics Ltd.，振幅分别为36.65%、33.81%、19.04%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223224a2050acc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223224a2050acc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RLMD","BK4007","BK4139"],"gpt_icon":0},{"id":"2490868978","title":"Relmada Therapeutics, Inc.盘中异动 早盘快速下挫5.87%报0.442美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490868978","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490868978?lang=zh_cn&edition=full","pubTime":"2024-12-11 22:31","pubTimestamp":1733927461,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日22时31分，Relmada Therapeutics, Inc.股票出现波动，股价大幅下跌5.87%。截至发稿，该股报0.442美元/股，成交量6.6861万股，换手率0.22%，振幅0.00%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Candel Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Synlogic, Inc.涨幅较大，Silexion Therapeutics Corp、Candel Therapeutics, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为365.60%、100.62%、97.27%，振幅较大的相关个股有60 Degrees Pharmaceuticals, Inc.、Synlogic, Inc.、Bioline Rx Ltd，振幅分别为7.69%、6.21%、5.03%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223101ab6fc977&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223101ab6fc977&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RLMD","BK4007","BK4139"],"gpt_icon":0},{"id":"2488197547","title":"Relmada Therapeutics, Inc.盘中异动 大幅下挫76.50%报0.651美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488197547","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488197547?lang=zh_cn&edition=full","pubTime":"2024-12-04 22:32","pubTimestamp":1733322732,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日22时32分，Relmada Therapeutics, Inc.股票出现波动，股价快速跳水76.50%。截至发稿，该股报0.651美元/股，成交量392.623万股，换手率13.01%，振幅2.74%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。其相关个股中，Cyclerion Therapeutics, Inc.、Heron Therapeutics, Inc.、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Cyclerion Therapeutics, Inc.、Can Fite Biopharma Ltd、Windtree Therapeutics, Inc.较为活跃，换手率分别为1238.61%、191.03%、111.34%，振幅较大的相关个股有Cyclerion Therapeutics, Inc.、Heron Therapeutics, Inc.、Eterna Therapeutics Inc.，振幅分别为53.42%、27.97%、13.56%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204223212a26c5dfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204223212a26c5dfd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","RLMD"],"gpt_icon":0},{"id":"2488901946","title":"Relmada Therapeutics, Inc.盘中异动 早盘股价大跌5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488901946","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488901946?lang=zh_cn&edition=full","pubTime":"2024-12-03 22:40","pubTimestamp":1733236803,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日22时40分，Relmada Therapeutics, Inc.股票出现波动，股价大幅下挫5.47%。截至发稿，该股报3.11美元/股，成交量8792股，换手率0.03%，振幅4.26%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。其相关个股中，Janux Therapeutics, Inc.、Coherus Biosciences, Inc.、Cytomx Therapeutics, Inc.涨幅较大，Nls Pharmaceutics Ltd.、Purple Biotech Ltd、Senti Biosciences, Inc.较为活跃，换手率分别为132.48%、73.75%、58.60%，振幅较大的相关个股有Coherus Biosciences, Inc.、Senti Biosciences, Inc.、Alpha Tau Medical Ltd C/Wts ，振幅分别为24.09%、23.90%、15.00%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203224003abf2fcd9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203224003abf2fcd9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RLMD","LENZ","BK4007"],"gpt_icon":0},{"id":"2485261287","title":"Relmada Therapeutics, Inc.盘中异动 股价大涨8.00%报2.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485261287","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485261287?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:44","pubTimestamp":1732286641,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时44分，Relmada Therapeutics, Inc.股票出现异动，股价快速上涨8.00%。截至发稿，该股报2.97美元/股，成交量2168股，换手率0.01%，振幅8.00%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Virpax Pharmaceuticals, Inc.、Exicure, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为900.70%、81.41%、69.14%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为44.82%、33.24%、30.69%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122224401a24e263c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122224401a24e263c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","RLMD"],"gpt_icon":0},{"id":"2484674900","title":"Relmada Therapeutics, Inc.盘中异动 大幅拉升5.81%报3.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484674900","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484674900?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:50","pubTimestamp":1731941442,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时50分，Relmada Therapeutics, Inc.股票出现波动，股价急速拉升5.81%。截至发稿，该股报3.19美元/股，成交量2.0748万股，换手率0.07%，振幅7.11%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Hcw Biologics Inc.、冠科美博、Fate Therapeutics, Inc.涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为546.77%、384.20%、286.53%，振幅较大的相关个股有Hcw Biologics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Fate Therapeutics, Inc.，振幅分别为118.81%、71.83%、62.38%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118225043971a7302&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118225043971a7302&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RLMD","BK4007","BK4139"],"gpt_icon":0},{"id":"2484051028","title":"Relmada Therapeutics, Inc.2024财年第三财季实现净利润-21.73百万美元，同比增加1.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484051028","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484051028?lang=zh_cn&edition=full","pubTime":"2024-11-17 00:03","pubTimestamp":1731773006,"startTime":"0","endTime":"0","summary":"11月17日，Relmada Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-21.73百万美元，同比增加1.23%；其中营业收入为0.00美元，每股基本收益为-0.72美元。从资产负债表来看，Relmada Therapeutics, Inc.总负债8.10百万美元，其中短期债务0.00美元，资产负债比为6.88，流动比率为6.89。机构评级：截至2024年11月17日，当前有4家机构对Relmada Therapeutics, Inc.目标价做出预测，其中目标均价为12.00美元，其中最低目标价为2.00美元，最高目标价为23.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000438a23e0727&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241117000438a23e0727&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RLMD","LENZ"],"gpt_icon":0},{"id":"2477598573","title":"Relmada Therapeutics, Inc.盘中异动 快速跳水6.47%报3.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477598573","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477598573?lang=zh_cn&edition=full","pubTime":"2024-10-22 22:45","pubTimestamp":1729608355,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日22时45分，Relmada Therapeutics, Inc.股票出现波动，股价急速下跌6.47%。截至发稿，该股报3.40美元/股，成交量2.7366万股，换手率0.09%，振幅2.48%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。其相关个股中，Ensysce Biosciences, Inc.、Genprex, Inc.、Sangamo Therapeutics, Inc.涨幅较大，Genprex, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为4212.97%、3575.74%、1923.87%，振幅较大的相关个股有Ensysce Biosciences, Inc.、Aptevo Therapeutics Inc.、Genprex, Inc.，振幅分别为165.44%、99.41%、81.46%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022224556a1e2d34a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022224556a1e2d34a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RLMD","LENZ","BK4007"],"gpt_icon":0},{"id":"2475685750","title":"Relmada Therapeutics, Inc.盘中异动 快速上涨5.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475685750","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475685750?lang=zh_cn&edition=full","pubTime":"2024-10-15 21:36","pubTimestamp":1728999410,"startTime":"0","endTime":"0","summary":"北京时间2024年10月15日21时36分，Relmada Therapeutics, Inc.股票出现异动，股价急速上涨5.97%。Relmada Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.22%。其相关个股中，Apollomics Inc C/Wts 01/04/2028 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Lipella Pharmaceuticals Inc.、Enveric Biosciences, Inc.、Gritstone Bio, Inc.较为活跃，换手率分别为249.50%、169.92%、144.09%，振幅较大的相关个股有Gritstone Bio, Inc.、Meiragtx Holdings Plc、Bright Minds Biosciences Inc.，振幅分别为29.63%、15.52%、14.05%。Relmada Therapeutics, Inc.公司简介：Relmada Therapeutics Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015213651971a05ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015213651971a05ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RLMD","BK4139","BK4007","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.relmada.com","stockEarnings":[{"period":"1week","weight":-0.0412},{"period":"1month","weight":-0.0312},{"period":"3month","weight":-0.0582},{"period":"6month","weight":4.7576},{"period":"1year","weight":10.3208},{"period":"ytd","weight":-0.2298}],"compareEarnings":[{"period":"1week","weight":-0.0128},{"period":"1month","weight":-0.0125},{"period":"3month","weight":0.0146},{"period":"6month","weight":0.0595},{"period":"1year","weight":0.1181},{"period":"ytd","weight":-0.0002}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Relmada Therapeutics, Inc.是私人控股公司，于2004年5月注册成立。该公司是一家临床阶段的生物制药公司，致力于开发用于治疗慢性疼痛的候选药物。该公司专注于开发d-methadone（右美沙酮，REL-1017），一种N-甲基-D-天冬氨酸（NMDA）受体拮抗剂。美沙酮是一种新的化学实体，可能解决中枢神经系统（CNS）疾病和其他疾病治疗中未满足医疗需求的领域。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.038602},{"month":2,"riseRate":0.625,"avgChangeRate":0.054653},{"month":3,"riseRate":0.571429,"avgChangeRate":-0.024636},{"month":4,"riseRate":0.714286,"avgChangeRate":0.052877},{"month":5,"riseRate":0.5,"avgChangeRate":0.173917},{"month":6,"riseRate":0.125,"avgChangeRate":-0.123736},{"month":7,"riseRate":0.75,"avgChangeRate":0.083628},{"month":8,"riseRate":0.5,"avgChangeRate":0.100482},{"month":9,"riseRate":0.875,"avgChangeRate":0.190291},{"month":10,"riseRate":0.5,"avgChangeRate":0.106137},{"month":11,"riseRate":0.375,"avgChangeRate":0.05543},{"month":12,"riseRate":0.5,"avgChangeRate":0.004602}],"exchange":"NASDAQ","name":"Relmada Therapeutics, Inc.","nameEN":"Relmada Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Relmada Therapeutics, Inc.(RLMD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Relmada Therapeutics, Inc.(RLMD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Relmada Therapeutics, Inc.,RLMD,Relmada Therapeutics, Inc.股票,Relmada Therapeutics, Inc.股票老虎,Relmada Therapeutics, Inc.股票老虎国际,Relmada Therapeutics, Inc.行情,Relmada Therapeutics, Inc.股票行情,Relmada Therapeutics, Inc.股价,Relmada Therapeutics, Inc.股市,Relmada Therapeutics, Inc.股票价格,Relmada Therapeutics, Inc.股票交易,Relmada Therapeutics, Inc.股票购买,Relmada Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Relmada Therapeutics, Inc.(RLMD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Relmada Therapeutics, Inc.(RLMD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}